LXRX

AS OF

Nov 15, 01:46 PM (EDT)

Price

$1.00

Change

-$0.06 (-5.66%)

Capitalization

383.18M

117 days until earnings call

OUR PRODUCTS

MOBILE APPS

GENERAL INFO

Help

LXRX Stock LXRX is expected to report earnings to rise+16.25% to -17 cents per share on August 01

GET DAILY SIGNALS

Get AI intraday signals

A.I.dvisor
at Tickeron.com

Buy or Sell

View Daily Signals

08/01/24

LXRX - Lexicon Pharmaceuticals

Q2'24

Est.

$-0.17

Q1'24

Est.

$-0.20

Q4'23

Beat

by $0.02

Q3'23

Est.

$-0.21

Q2'23

Missed

by $0.04

The last earnings report on March 31 showed earnings per share of -20 cents, meeting the estimate of -20 cents. P/B Ratio (2.791) is normal, around the industry mean (12.411). P/E Ratio (0.000) is within average values for comparable stocks, (150.866). LXRX's Projected Growth (PEG Ratio) (0.000) is very low in comparison to the industry average of (1.490). Dividend Yield (0.000) settles around the average of (0.066) among similar stocks. P/S Ratio (227.273) is also within normal values, averaging (218.033). With 810.09K shares outstanding, the current market capitalization sits at 809.74M.

View a ticker or compare two or three

Compare

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a company, which engages in discovery and development of breakthrough treatments for human disease

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

2445 Technology Forest Boulevard

Phone

+1 281 863-3000

Employees

285

Web

https://www.lexpharma.com